Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoquercetin to Prevent VTE in Cancer Patients
NCT02195232Phase 3Completed
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoquercetin in venous thromboembolism (VTE). Started Jan 2015; status: completed.
02
Drugs
isoquercetin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02195232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195232.